Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

September 01, 1996; 47 (3) BRIEF COMMUNICATIONS

Hippocampal formation size predicts declining memory performance in normal aging

J. Golomb, A. Kluger, M. J. de Leon, S. H. Ferris, M. Ph Mittelman, J. Cohen, A. E. George
First published September 1, 1996, DOI: https://doi.org/10.1212/WNL.47.3.810
J. Golomb
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. Kluger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. J. de Leon
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. H. Ferris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Ph Mittelman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. Cohen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A. E. George
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Hippocampal formation size predicts declining memory performance in normal aging
J. Golomb, A. Kluger, M. J. de Leon, S. H. Ferris, M. Ph Mittelman, J. Cohen, A. E. George
Neurology Sep 1996, 47 (3) 810-813; DOI: 10.1212/WNL.47.3.810

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
67

Share

  • Article
  • Figures & Data
  • Info & Disclosures
Loading

Abstract

Hippocampal formation (HF) atrophy, although common in normal aging, has unknown clinical consequences.We used MRI to derive HF size measurements at baseline on 44 cognitively normal older adults entering a longitudinal study of memory function (mean age = 68.4 years, mean follow-up = 3.8 years). Only one subject became demented at follow-up. Multiple regression analyses controlling for age, gender, education, and diffuse cerebral atrophy revealed that HF size significantly predicted longitudinal change on memory tests previously found sensitive to decline in normal aging. These results indicate HF atrophy may be a risk factor for accelerated memory dysfunction in normal aging.

NEUROLOGY 1996;47: 810-813

Radiographically evident atrophy involving the hippocampal formation occurs in Alzheimer's disease [1,2] and also in nondemented elderly patients with mild cognitive impairment. [3] Nevertheless, lesser degrees of hippocampal atrophy may affect approximately one-third of elderly persons without any clinical evidence for cognitive dysfunction. [4]

In a recent study, [5] we obtained MRI derived measurements of hippocampal formation (HF) size on a group of cognitively normal elderly research volunteers. In this sample, there was a highly significant correlation (r = 0.49, p < 0.001), independent of diffuse cortical atrophy, between hippocampal size and a composite index of delayed secondary memory performance. In this study, we analyzed the results of follow-up memory tests administered to members of this sample to determine whether longitudinal deterioration in recall performance would significantly correlate with the baseline hippocampal formation size measurements.

Methods.

Subjects.

Of all medically healthy and cognitively normal older adults participating in a study of memory impairment at the New York University Aging and Dementia Research Center, 101 individuals received clinical and psychometric follow-up evaluations between 2 and 6 years subsequent to baseline. These subjects consisted of community-dwelling research volunteers over 55 years of age who at baseline received a score of 28 or greater on the Mini-Mental Status Examination [6] and a rating of 1 or 2 on the Global Deterioration Scale [7] (GDS). GDS ratings of 1 and 2 identify subjects who manifest no evidence for intellectual impairment on the basis of a comprehensive psychiatric interview. In clinical studies of dementia, this GDS classification is used to define samples of cognitively normal control subjects. All subjects received a comprehensive battery of medical, neurologic, psychiatric, neuroradiologic, and laboratory examinations (blood and urine) and were excluded if any of these evaluations suggested conditions that could adversely affect brain functioning.

MRI evaluations.

Of the 101 longitudinally evaluated subjects, 44 received MRI scans at baseline that were used to derive head-size adjusted measurements of the HF, the superior temporal gyrus (STG), and the subarachnoid CSF (to estimate generalized cerebral atrophy). The STG was chosen as a control region because its neuropsychologic role is believed to be relatively independent of memory function and because it could be easily measured on the same set of cross-sectional images used to sample the HF. These measurements were made at baseline as part of a previously published crossectional study using techniques that were described in detail. [5]

Briefly, using a 1.5-T Philips Gyroscan (Shelton, CT), 4-mm-thick, T sub 1-weighted spin-echo images through the temporal lobe were acquired in a plane oriented 90 degrees to the long axis of the hippocampus. Slices depicting the body of the hippocampus from immediately posterior to the hippocampal head to the level of the posterior pulvinar were used to measure the size of the HF, the STG, and the subarachnoid CSF compartment (SCSF). These measurements were made directly from the digital images using proprietary region analysis software. HF and STG values were combined for the right and left hemisphere and, together with SCSF, regressed on a measurement of supratentorial intracranial volume to adjust for intersubject head size variability. The resulting residualized scores (rHF, rSTG, and rSCSF) were used in subsequent statistical analyses.

Psychometric evaluations.

For the 44 subjects with quantitative MRI data, the only neuropsychologic instrument measuring memory performance to be administered consistently both at baseline and at follow-up was the Guild Memory Test. [8] This examination consists of immediate (initial) and delayed recall of paragraphs and paired associates and a nonverbal test of memory for designs. Forward digit span is used to assess primary memory.

The Guild subtests selected for the statistical analyses were those we found sensitive to longitudinal decline in normal aging. This was investigated by means of a separate analysis of the larger parent sample (n = 101). The demographic characteristics of these subjects as well as the 44 with baseline HF, STG, and SCSF measurements are presented in Table 1.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 1. Demographic characteristics of cognitively normal subjects (GDS 1-2, MMSE >or=to 28) with longitudinal psychometric follow-up (Guild Memory Test)

Results.

At follow-up, only 1 of 44 subjects with baseline MRI data became demented (GDS rating = 4). Thirteen subjects (29.5%) received a GDS rating of 3, indicating development of mild cognitive impairment as assessed by a comprehensive psychiatric interview. Similar results were found in the larger parent sample (n = 101, see Table 1).

Guild Memory Test stability in normal aging.

The six Guild subtests were examined for longitudinal change in the parent sample (n = 101). Only the paragraph recall subtests but not the paired associate, design, or digit span subtests demonstrated significant decline Figure 1.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Figure 1. Baseline and follow-up Guild Memory Test raw scores for cognitively normal elderly persons without baseline evidence for cognitive impairment (GDS 1-2, MMSE >or=to 28). The demographic characteristics of this sample is provided in Table 1. Longitudinal decline was evident only on the paragraph recall subtests (paired tdelay = 5.96, p < 0.001; paired tinitial = 4.62, p < 0.001).

HF size and longitudinal changes in paragraph recall.

Hierarchical multiple linear-regression models [9] were used to determine whether hippocampal formation size at baseline was significantly related to change in the paragraph recall scores over the follow-up interval. Using the paragraph delayed recall follow-up score as the dependent variable, the baseline score was entered at step 1. Beyond this point, additional independent variables will serve as predictors of longitudinal paragraph score change. In step 2, age at baseline, gender, years of education, and length of time to follow-up were entered as covariates. Entering hippocampal size (rHF) at the third step significantly increased the R2 of the model. In a parallel analysis with the initial recall paragraph score as the dependent variable, a significant Delta R2 at step 3 was also observed Table 2. When entered at the third step, rSTG did not produce a significant Delta R2 in either the delayed or initial recall model.

View this table:
  • View inline
  • View popup
  • Download powerpoint

Table 2. Hierarchical multiple-regression models predicting delayed and initial paragraph scores at follow-up

To determine whether the predictive effect of hippocampal size on paragraph recall change was independent of generalized cerebral atrophy, rSCSF was entered at the third step. In the delayed recall model, rHF still produced a significant increment in R2 when added to the equation as a fourth step (Delta R2 = 0.07, p < 0.01). In the initial recall model, entering rHF after rSCSF produced a Delta R2 of 0.06 (p = 0.07).

HF size and longitudinal changes in GDS score.

After covarying for the effects of age and gender, only baseline rHF, not rSTG or rSCSF, was significantly reduced in the 14 subjects who received a GDS score greater than 2 at follow-up (ANCOVA: FHF = 6.44, p < 0.05; FSTG = 0.01, NS; FSCSF = 0.64, NS).

Discussion.

In this study, baseline MRI measurements of HF size significantly predicted a decline in memory performance observed in a research sample of cognitively normal older adults. Although anatomic specificity for this result is suggested by its independence from the effects of diffuse gyral atrophy and by the failure of rSTG to load as a significant predictor, it is possible that measurements of other individual brain structures involved in memory processing but not sampled in this study (e.g., frontal, thalamic, cingulate) might also be useful as predictors of longitudinal memory change.

Nearly 30% of the 44 cognitively normal subjects with quantitative MRI data (and 20% of the larger parent sample of 101) developed mild cognitive impairment (GDS 3) at follow-up. To our knowledge, no population-based studies using the GDS classification scheme have examined the incidence with which normal subjects develop mild impairments. It is therefore uncertain whether the percent conversion observed in our carefully screened research volunteers is representative of the general elderly community. Nevertheless, in the present study, cognitively normal subjects with mild impairment at follow-up had significantly smaller hippocampi at baseline than subjects who remained stable. Using subjective techniques of MRI and CT interpretation, we previously demonstrated hippocampal atrophy to predict the emergence of dementia in elderly adults with such mild cognitive impairment. [2] Further research will determine whether hippocampal atrophy should be considered a risk factor for dementia in cognitively normal older persons.

The pathologic basis of hippocampal atrophy in normal aging is currently unknown. Hippocampal neurofibrillary tangles are commonly found in non-demented older persons, [10] but their relationship to radiographically observed volume reductions are unclear. It is likewise unclear whether all individuals with hippocampal neurofibrillary pathology are destined to develop AD. The significance of HF atrophy in normal aging requires further clinical and neuropathologic investigation.

Acknowledgment

We thank William and Sylvia Silberstein for their generous support.

  • Copyright 1996 by Advanstar Communications Inc.

REFERENCES

  1. 1.↵
    de Leon MJ, Convit A, de Santi S, et al. The hippocampus in aging and Alzheimer's disease. Neuroimaging Clin North Am 1995;5:1-17.
    OpenUrl
  2. 2.↵
    de Leon MJ, Golomb J, George AE, et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol 1993;14:897-906.
    OpenUrl
  3. 3.↵
    Convit A, de Leon MJ, Tarshish C, et al. Hippocampal volume losses in minimally impaired elderly. Lancet 1995;345:266.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Golomb J, de Leon MJ, Kluger A, George AE, Tarshish C, Ferris SH. Hippocampal atrophy in normal aging: an association with recent memory impairment. Arch Neurol 1993;50:967-976.
    OpenUrl
  5. 5.↵
    Golomb J, Kluger A, de Leon MJ, et al. Hippocampal formation size in normal human aging: a correlate of delayed secondary memory performance. Learn Mem 1994;1:45-54.
    OpenUrl
  6. 6.↵
    Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
    OpenUrlPubMed
  7. 7.↵
    Reisberg B, Ferris SH, de Leon MJ, Crook T. The global deterioration scale for assessment of primary degenerative dementia. Am J Psychiatry 1982;139:1136-1139.
    OpenUrlPubMed
  8. 8.↵
    Gilbert JG, Levee RF, Catalano FL. A preliminary report on a new memory scale. Percept Mot Skills 1968;27:277-278.
    OpenUrl
  9. 9.↵
    Cohen J, Cohen P. Applied multiple regression/correlation analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum Associates, 1983.
  10. 10.↵
    Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991;12:295-312.
    OpenUrl

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • Abstract
    • Methods.
    • Results.
    • Discussion.
    • Acknowledgment
    • REFERENCES
  • Figures & Data
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (5)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise